Back to Awarded Treatment Trials
Awarded Trial: 11T-008
Grant ID
11T-008
Illness
bipolar
Primary Drug/Intervention
iradipine
Primary Dosage
10 mg
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Cancelled
Investigator
Perlis
Sample Size
30
Duration of Study Period for Each Subject
28
Outcome Measurements
N/A
Results
Study was cancelled due to low patient recruitment.
Publication
N/A
Link
N/A
PI Name
Roy Perlis
Degree
MD
Center
N/A
Institution
Massachusetts General Hospital
Address
185 Cambridge St.
City or Town
Boston
State or Province
MA
Zip or Postal Code
2114
Country
USA
Email Address
rperlis@partners.org